Latest News & Features
Genetics
The High Court of Australia is set to consider the Myriad Genetics case concerning whether isolated genetic material is patentable subject matter. 16 February 2015
Americas
Law firm Kaye Scholer has added a team of three life sciences and technology lawyers to its intellectual property group. 13 February 2015
Americas
Novartis has sued drug company BPI Labs for alleged patent infringement after it requested permission to market a generic version of Novartis’s bone cancer drug Zometa. 12 February 2015
Big Pharma
A medical aid non-profit organisation has opposed a European patent held by pharmaceutical company Gilead that covers its anti-hepatitis C drug Sovaldi. 11 February 2015
Americas
Bayer’s animal health division has filed for a declaratory judgment that SHP Chemical has infringed three patents covering a range of products that control fleas affecting cats and dogs. 9 February 2015
Americas
US pharmaceutical company Pfizer has agreed to buy drug company Hospira, in an acquisition that will include its biosimilar portfolio. 6 February 2015
Americas
Law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has bolstered its life sciences practice again, adding a group of five lawyers to its Washington, DC office. 6 February 2015
Asia
Another party has thrown its hat into the ring in the fight to stop the issue of an Indian patent covering Sovaldi, a hepatitis C drug. 4 February 2015
Americas
Law firm Kilpatrick Townsend & Stockton has added a chemistry and life sciences team to its Washington, DC office. 4 February 2015
Americas
Pharmaceutical company Eli Lilly has reported that its US revenue in 2014 dipped by 29% compared to the previous year, laying the blame on key patents, including those for Cymbalta and Evista, expiring. 3 February 2015